Drawing for BIOSCREEN

USPTO serial 79429190

BIOSCREEN

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
O'BRIEN, JENNIFER LYNN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOSCREEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey A. Smith

Jeffrey A. Smith Millen, White, Zelano & Branigan, P.C.2200 Clarendon BoulevardSuite 1400Arlington, VA 22201

Goods and services

ClassDescriptionStatusFirst use
009Biochemistry, clinical chemistry and microbiology apparatus and instruments, namely, apparatus and instruments for measuring the growth of microorganisms, for scientific, research or laboratory use; computer software, namely, downloadable computer software for controlling apparatus for measuring the growth of microorganisms and for analyzing the results thereof, for use in the fields of biochemistry, clinical chemistry and microbiology; none being apparatus or instruments performing qualitative analyses of micro-organisms in aqueous systemsACTIVE—
010Medical apparatus and instruments, namely, computer-controlled medical apparatus and instruments for automating measurements of the growth of microorganisms, for medical diagnostic purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 21, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 2, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 1, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 1, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 4, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 4, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 4, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 30, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 29, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 29, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2025RFNTREFUSAL PROCESSED BY IB—
Dec 1, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 1, 2025RFRRREFUSAL PROCESSED BY MPU—
Oct 12, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 11, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 1, 2025DOCKASSIGNED TO EXAMINER—
Aug 5, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 5, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 5, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 31, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance